Titre : Anatoxine staphylococcique

Anatoxine staphylococcique : Questions médicales fréquentes

Termes MeSH sélectionnés :

Lymph Node Excision
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Anatoxine staphylococcique : Questions médicales les plus fréquentes", "headline": "Anatoxine staphylococcique : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Anatoxine staphylococcique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-07", "dateModified": "2025-05-02", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Anatoxine staphylococcique" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Toxoïdes", "url": "https://questionsmedicales.fr/mesh/D014121", "about": { "@type": "MedicalCondition", "name": "Toxoïdes", "code": { "@type": "MedicalCode", "code": "D014121", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.691" } } }, "about": { "@type": "MedicalCondition", "name": "Anatoxine staphylococcique", "alternateName": "Staphylococcal Toxoid", "code": { "@type": "MedicalCode", "code": "D013208", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Fiona P Havers", "url": "https://questionsmedicales.fr/author/Fiona%20P%20Havers", "affiliation": { "@type": "Organization", "name": "Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States. Electronic address: fhavers@cdc.gov." } }, { "@type": "Person", "name": "Susan Hariri", "url": "https://questionsmedicales.fr/author/Susan%20Hariri", "affiliation": { "@type": "Organization", "name": "Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States." } }, { "@type": "Person", "name": "Nasamon Wanlapakorn", "url": "https://questionsmedicales.fr/author/Nasamon%20Wanlapakorn", "affiliation": { "@type": "Organization", "name": "Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand." } }, { "@type": "Person", "name": "Donchida Srimuan", "url": "https://questionsmedicales.fr/author/Donchida%20Srimuan", "affiliation": { "@type": "Organization", "name": "Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand." } }, { "@type": "Person", "name": "Thaksaporn Thatsanathorn", "url": "https://questionsmedicales.fr/author/Thaksaporn%20Thatsanathorn", "affiliation": { "@type": "Organization", "name": "Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Radiation, Lymph Node Dissection, or Both: Management of Lymph Node Micrometastases from Merkel Cell Carcinoma.", "datePublished": "2023-04-27", "url": "https://questionsmedicales.fr/article/37106277", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1245/s10434-023-13437-z" } }, { "@type": "ScholarlyArticle", "name": "Clinical outcomes of neoadjuvant therapy followed by selective inguinal lymph node dissection and total mesorectal excision for metastasized low rectal cancer.", "datePublished": "2022-12-28", "url": "https://questionsmedicales.fr/article/36577899", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00423-022-02739-7" } }, { "@type": "ScholarlyArticle", "name": "Robotic versus laparoscopic total mesorectal excision with lateral lymph node dissection for advanced rectal cancer: A systematic review and meta-analysis.", "datePublished": "2024-05-29", "url": "https://questionsmedicales.fr/article/38809911", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0304031" } }, { "@type": "ScholarlyArticle", "name": "Inguinal Lymph-Node Ratio (LNR) as a predictor of Pelvic Lymph-Node Metastasis in squamous cell carcinoma of penis.", "datePublished": "2023-06-08", "url": "https://questionsmedicales.fr/article/37315351", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.suronc.2023.101964" } }, { "@type": "ScholarlyArticle", "name": "Factors Associated With Lymph Node Yield and Effects of Lymph Node Density on Survival of Patients With Pulmonary Sarcomatoid Carcinoma.", "datePublished": "2022-10-17", "url": "https://questionsmedicales.fr/article/36256867", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/COC.0000000000000946" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Mélanges complexes", "item": "https://questionsmedicales.fr/mesh/D045424" }, { "@type": "ListItem", "position": 3, "name": "Produits biologiques", "item": "https://questionsmedicales.fr/mesh/D001688" }, { "@type": "ListItem", "position": 4, "name": "Vaccins", "item": "https://questionsmedicales.fr/mesh/D014612" }, { "@type": "ListItem", "position": 5, "name": "Toxoïdes", "item": "https://questionsmedicales.fr/mesh/D014121" }, { "@type": "ListItem", "position": 6, "name": "Anatoxine staphylococcique", "item": "https://questionsmedicales.fr/mesh/D013208" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Anatoxine staphylococcique - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Anatoxine staphylococcique", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-19", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Anatoxine staphylococcique", "description": "Comment diagnostiquer une infection staphylococcique ?\nQuels tests sont utilisés pour détecter l'anatoxine ?\nQuels symptômes indiquent une infection staphylococcique ?\nComment différencier les types de staphylocoques ?\nQuel rôle joue l'anatoxine dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D013208?mesh_terms=Lymph+Node+Excision&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Anatoxine staphylococcique", "description": "Quels sont les symptômes d'une intoxication par anatoxine ?\nComment se manifestent les infections cutanées staphylococciques ?\nQuels signes indiquent une infection systémique ?\nLes symptômes varient-ils selon le type de staphylocoque ?\nQuels symptômes sont associés à l'anatoxine staphylococcique ?", "url": "https://questionsmedicales.fr/mesh/D013208?mesh_terms=Lymph+Node+Excision&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Anatoxine staphylococcique", "description": "Comment prévenir les infections staphylococciques ?\nL'anatoxine staphylococcique est-elle vaccinante ?\nQuelles mesures de prévention en milieu hospitalier ?\nLes personnes à risque doivent-elles se faire vacciner ?\nComment éviter la transmission en milieu communautaire ?", "url": "https://questionsmedicales.fr/mesh/D013208?mesh_terms=Lymph+Node+Excision&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Anatoxine staphylococcique", "description": "Quel traitement est recommandé pour une infection staphylococcique ?\nL'anatoxine staphylococcique est-elle un traitement ?\nComment traiter une réaction à l'anatoxine ?\nQuels soins sont nécessaires pour les infections cutanées ?\nQuand utiliser des antibiotiques pour les infections staphylococciques ?", "url": "https://questionsmedicales.fr/mesh/D013208?mesh_terms=Lymph+Node+Excision&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Anatoxine staphylococcique", "description": "Quelles complications peuvent survenir avec une infection staphylococcique ?\nL'anatoxine peut-elle provoquer des effets secondaires ?\nQuels sont les risques d'une septicémie staphylococcique ?\nComment gérer les complications d'une infection ?\nLes infections staphylococciques peuvent-elles être chroniques ?", "url": "https://questionsmedicales.fr/mesh/D013208?mesh_terms=Lymph+Node+Excision&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Anatoxine staphylococcique", "description": "Quels sont les principaux facteurs de risque d'infection staphylococcique ?\nLes personnes diabétiques sont-elles plus à risque ?\nLes athlètes sont-ils à risque d'infections cutanées ?\nComment l'hygiène influence-t-elle le risque d'infection ?\nLes personnes âgées sont-elles plus vulnérables ?", "url": "https://questionsmedicales.fr/mesh/D013208?mesh_terms=Lymph+Node+Excision&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une infection staphylococcique ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des cultures bactériennes et des tests de sensibilité." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour détecter l'anatoxine ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sérologiques peuvent être utilisés pour détecter des anticorps contre l'anatoxine." } }, { "@type": "Question", "name": "Quels symptômes indiquent une infection staphylococcique ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent rougeurs, gonflements, douleurs et parfois fièvre." } }, { "@type": "Question", "name": "Comment différencier les types de staphylocoques ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des tests biochimiques et des analyses génétiques aident à identifier les espèces." } }, { "@type": "Question", "name": "Quel rôle joue l'anatoxine dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'anatoxine est utilisée pour évaluer la réponse immunitaire aux infections staphylococciques." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une intoxication par anatoxine ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent inclure des nausées, vomissements et diarrhées." } }, { "@type": "Question", "name": "Comment se manifestent les infections cutanées staphylococciques ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Elles se manifestent par des furoncles, des abcès et des éruptions cutanées." } }, { "@type": "Question", "name": "Quels signes indiquent une infection systémique ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre élevée, frissons, et signes de septicémie peuvent indiquer une infection systémique." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon le type de staphylocoque ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier selon la souche et le site d'infection." } }, { "@type": "Question", "name": "Quels symptômes sont associés à l'anatoxine staphylococcique ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent inclure des réactions allergiques et des douleurs au site d'injection." } }, { "@type": "Question", "name": "Comment prévenir les infections staphylococciques ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Maintenir une bonne hygiène et désinfecter les blessures aide à prévenir les infections." } }, { "@type": "Question", "name": "L'anatoxine staphylococcique est-elle vaccinante ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle est utilisée pour immuniser contre certaines infections staphylococciques." } }, { "@type": "Question", "name": "Quelles mesures de prévention en milieu hospitalier ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Des protocoles stricts d'hygiène et de désinfection sont essentiels en milieu hospitalier." } }, { "@type": "Question", "name": "Les personnes à risque doivent-elles se faire vacciner ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes à risque d'infections staphylococciques devraient envisager la vaccination." } }, { "@type": "Question", "name": "Comment éviter la transmission en milieu communautaire ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Éviter le partage d'objets personnels et maintenir une bonne hygiène personnelle." } }, { "@type": "Question", "name": "Quel traitement est recommandé pour une infection staphylococcique ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les antibiotiques sont souvent prescrits, selon la sensibilité de la souche." } }, { "@type": "Question", "name": "L'anatoxine staphylococcique est-elle un traitement ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Non, c'est un toxoïde utilisé pour la prévention, pas pour le traitement." } }, { "@type": "Question", "name": "Comment traiter une réaction à l'anatoxine ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les réactions allergiques peuvent nécessiter des antihistaminiques ou des corticostéroïdes." } }, { "@type": "Question", "name": "Quels soins sont nécessaires pour les infections cutanées ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Un drainage des abcès et des soins locaux sont souvent nécessaires." } }, { "@type": "Question", "name": "Quand utiliser des antibiotiques pour les infections staphylococciques ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les antibiotiques sont utilisés lorsque l'infection est confirmée et nécessite un traitement." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec une infection staphylococcique ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des infections profondes, des septicémies et des chocs toxiques." } }, { "@type": "Question", "name": "L'anatoxine peut-elle provoquer des effets secondaires ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des effets secondaires comme des douleurs au site d'injection et des réactions allergiques peuvent survenir." } }, { "@type": "Question", "name": "Quels sont les risques d'une septicémie staphylococcique ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "La septicémie peut entraîner des défaillances organiques et un risque accru de mortalité." } }, { "@type": "Question", "name": "Comment gérer les complications d'une infection ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Une prise en charge rapide avec des antibiotiques et des soins intensifs est cruciale." } }, { "@type": "Question", "name": "Les infections staphylococciques peuvent-elles être chroniques ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines infections peuvent devenir chroniques et nécessiter un traitement prolongé." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque d'infection staphylococcique ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent un système immunitaire affaibli, des interventions chirurgicales et des blessures." } }, { "@type": "Question", "name": "Les personnes diabétiques sont-elles plus à risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le diabète augmente le risque d'infections staphylococciques en raison de la circulation sanguine altérée." } }, { "@type": "Question", "name": "Les athlètes sont-ils à risque d'infections cutanées ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les athlètes peuvent être à risque en raison de blessures et de contacts fréquents." } }, { "@type": "Question", "name": "Comment l'hygiène influence-t-elle le risque d'infection ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Une mauvaise hygiène augmente le risque d'infections staphylococciques, surtout dans les milieux communautaires." } }, { "@type": "Question", "name": "Les personnes âgées sont-elles plus vulnérables ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées ont un risque accru en raison d'un système immunitaire affaibli." } } ] } ] }

Sources (7894 au total)

Radiation, Lymph Node Dissection, or Both: Management of Lymph Node Micrometastases from Merkel Cell Carcinoma.

Regional lymph node micrometastases from Merkel cell carcinoma (MCC) can be treated with completion lymph node dissection (CLND) and/or radiation therapy (RT). It is unclear how these options compare ... This retrospective cohort study used data from years 2012-2019 of the National Cancer Database. Patients with MCC and clinically negative, but pathologically positive, lymph node metastases who receiv... A total of 962 patients were included [median (interquartile range) age, 74 (67-80) years, 662 (68.8%) male patients, 926 (96.3%) white patients]. The majority (63%, n = 606) had a CLND only, while 18... The usage of RT for nodal micrometastasis in MCC is increasing as compared with CLND. This strategy appears to be safe, with no significant difference in survival outcomes....

Clinical outcomes of neoadjuvant therapy followed by selective inguinal lymph node dissection and total mesorectal excision for metastasized low rectal cancer.

Rectal or anal canal adenocarcinoma with inguinal lymph node metastasis (ILNM) is rare and is associated with poor prognostic outcomes. This study aimed to elucidate the clinical significance of neoad... This study enrolled 15 consecutive patients who underwent neoadjuvant therapy and curative resection for rectal or anal canal adenocarcinoma with clinically suspected ILNM between 2005 and 2019 at a s... Out of the15 patients, 11 were treated with neoadjuvant chemoradiation, three with chemotherapy, and one with chemoradiation followed by chemotherapy. Fluorodeoxyglucose (FDG)-positron emission tomogr... In patients with rectal or anal canal adenocarcinoma associated with clinical ILNM, radical resection with neoadjuvant therapy provides a good long-term survival....

Robotic versus laparoscopic total mesorectal excision with lateral lymph node dissection for advanced rectal cancer: A systematic review and meta-analysis.

Lateral pelvic node dissection (LPND) poses significant technical challenges. Despite the advent of robotic surgery, determining the optimal minimally invasive approach remains a topic of debate. This... This meta-analysis was conducted according to the Preferred Reporting Items for Systematic Review and Meta-analysis (PRISMA) 2020 and AMSTAR 2 (Assessing the Methodological Quality of Systematic Revie... Six eligible studies involving 652 patients (316 and 336 in the R-LPND and L-LPND groups, respectively) were retrieved. The robotic approach demonstrated favourable outcomes compared with the laparosc... In summary, the robotic approach is a safe and feasible alternative for Total Mesorectal Excision (TME) with LPND in advanced rectal cancer. Notably, it is associated with lower morbidity, particularl...

Inguinal Lymph-Node Ratio (LNR) as a predictor of Pelvic Lymph-Node Metastasis in squamous cell carcinoma of penis.

To determine the predictors of pelvic lymph-node metastasis in cases of squamous cell carcinoma (SCC) of penis.... Data was retrospectively collected from 267 cases of SCC penis that presented at our institute between 2009 and 2019. Univariate and multivariate logistic regression models were used to identify indep... Pelvic Lymph-Node Metastasis (PLNM) was pathologically detected in 56 groins (29.2%). A cut-off of 0.25 was calculated for LNR based on ROC. LNR >0.25 (p = 0.003), ENE (p = 0.037), and LVI (p = 0.043)... LNR >0.25, LVI and, ENE are independent predictors of PLNM. The discriminative ability of LNR was better than PLN. PLND could be avoided if no risk factors are present....

Factors Associated With Lymph Node Yield and Effects of Lymph Node Density on Survival of Patients With Pulmonary Sarcomatoid Carcinoma.

The objective of this study was to identify factors associated with lymph node yield (LNY) during surgeries for pulmonary sarcomatoid carcinoma (PSC) and to determine effects of lymph node density (LN... The SEER Research Plus database was searched for data on patients with PSC from 1988 to 2018. Poisson regression was used of all patients with PSC to identify relevant factors associated with LNY. Uni... There were 545 eligible patients in the study sample, 175 of which were LN-positive. These patients had significantly lower 5-year OS than those with no positive LNs ( P <0.001). Poisson regression an... Patients with PSC with high LND experienced worse outcomes than those with low LND. Further risk stratification of patients with PSC may help to improve survival benefits based on prognostic indicator...

Impact of lymph node ratio and number of lymph node metastases on survival and recurrence in laryngeal squamous cell carcinoma.

The aim of this study is to assess the impact of lymph node ratio (LNR) and number of positive lymph nodes (NPLN) on mortality and recurrence rates in patients with laryngeal squamous cell carcinoma.... We conducted a retrospective multicenter international study involving 24 Otorhinolaryngology-Head and Neck Surgery divisions. Disease-specific survival (DSS) and disease-free survival (DFS) were eval... 2507 patients met the inclusion criteria. DSS and DFS were significantly different in the groups of patients stratified according to LNR and NPLN. The 5-year DSS and DFS based on LNR and NPLN demonstr... Our data demonstrate the potential prognostic value of NPLN and LNR in laryngeal squamous cell carcinoma....

Metastatic lymph node ratio as an important prognostic factor in advanced gallbladder carcinoma with at least 6 lymph nodes retrieved.

The metastatic lymph node (LN) ratio (LNR) has shown to be an important prognostic factor in various gastrointestinal malignancies. Nevertheless, the prognostic significance of LNR in gallbladder carc... From January 2007 to January 2018, 144 advanced GBC patients (T2-4 stages) who underwent curative surgery with at least 6 LNs retrieved were enrolled. Receiver operating characteristic (ROC) curve was... The optimal cut-off point for LNR was 0.28 according to the ROC curve. LNR>0.28 was associated with higher rate of D2 LN dissection (P=0.004) and higher tumor stages (P<0.001). Extent of liver resecti... LNR is correlated to advanced GBC prognosis and is a potential prognostic factor for advanced GBC with at least 6 LNs retrieved....

RATIO OF METASTATIC LYMPH NODES VS. RESECTED LYMPH NODES (N-RATIO) HAS PROGNOSTIC IMPLICATIONS IN GASTRIC CANCER.

Lymph node status is vital for gastric cancer (GC) prognosis, but the conventional pN stage may be limited by variations in lymphadenectomy and stage migration. The N-Ratio, which assesses the ratio o... To assess N-Ratios prognostic value in GC, particularly in patients with <25 resected lymph nodes.... Patients who underwent gastrectomy with curative intent for GC were retrospectively evaluated. The N-Ratio categories were determined using the ROC curve method, and the area under the curve (AUC) was... A total of 561 GC patients were included in the study, 57% had pN+ status, and 17.5% had <25 resected lymph nodes. N-Ratio, with a mean of 0.12, predicted survival with 74% accuracy (AUC=0.74; 95%CI 0... N-Ratio influenced survival in GC patients, especially in advanced lymph node disease (N-Ratio 3). Considering that N-Ratio does not impact pN0 cases, individualized prognosis assessment is essential ...

N1 lymph node detection in lymph node harvesting in non-small cell lung cancer: Formaldehyde exposure is a drawback?

This study aimed to evaluate the effect of lymph node dissection method on staging results, diagnosis of tumor metastasis in single or multiple N1 lymph nodes and survival rates in patients with non-s... Patients with NSCLC who underwent anatomic resection between September 2014 and October 2019 were examined prospectively. All patients with similar clinico-demographic characteristics were randomly as... There were no significant differences in N1 lymph node positivity between the two groups (p = 0.482). On average 9.08 lymph node sampling was performed in the surgical group and 2.39 in the pathology ... It is easier to detect lymph node involvement without introducing formaldehyde into the sample. We recommend that N1 lymph node dissection be performed on fresh specimens to detect more lymph node inv...